Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Jak2
REST API REST API
Rattus norvegicus
Jak2 is differentially expressed in 66 experiments: 41 organism parts: frontal cortex, kidney, ... (39 more);, 5 disease states: normal, BDL 7 days, ... (3 more);, 10 cell types 10 compound treatments 11 clinical treatments and 15 other conditions.
Orthologs F1NQU4_CHICK (Gallus gallus)   Jak2 (Mus musculus)   jak2a (Danio rerio)   JAK2 (Homo sapiens)   Q4H3A3_CIOIN (Ciona intestinalis)   jak2b (Danio rerio)   PR2 (Drosophila melanogaster)   jak2 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term endomembrane system, cytosol, response to antibiotic, response to oxidative stress, positive regulation of nitric oxide biosynthetic process, elevation of cytosolic calcium ion concentration, negative regulation of DNA binding, protein binding, SH2 domain binding, cytoskeleton, cytokine-mediated signaling pathway, cytoplasm, histone binding, negative regulation of cell proliferation, positive regulation of cell proliferation, membrane, hormone-mediated signaling pathway, G-protein coupled receptor protein signaling pathway, protein tyrosine kinase activity, receptor binding, insulin receptor substrate binding, negative regulation of heart contraction, nuclear matrix, heme binding, membrane fraction, positive regulation of apoptosis, positive regulation of phosphoprotein phosphatase activity, activation of MAPKK activity, ATP binding, transferase activity, transferring phosphorus-containing groups, protein kinase binding, nucleus, nucleotide binding, protein serine/threonine kinase activity, acetylcholine receptor binding, JAK-STAT cascade, chromatin modification, non-membrane spanning protein tyrosine kinase activity, signal transduction, protein kinase activity, caveola, intracellular protein kinase cascade, positive regulation of cell-substrate adhesion, tumor necrosis factor-mediated signaling pathway, positive regulation of growth hormone receptor signaling pathway, mineralocorticoid receptor signaling pathway, response to hydroperoxide, neuroprotection, positive regulation of peptidyl-tyrosine phosphorylation, negative regulation of cell-cell adhesion, response to tumor necrosis factor, positive regulation of protein import into nucleus, translocation, histone kinase activity (H3-Y41 specific), axon regeneration, platelet-derived growth factor receptor signaling pathway, erythrocyte differentiation, positive regulation of DNA binding, growth hormone receptor binding, positive regulation of cell migration, histone H3-Y41 phosphorylation, positive regulation of insulin secretion, interleukin-12 receptor binding, tyrosine phosphorylation of Stat1 protein, positive regulation of tyrosine phosphorylation of Stat5 protein, positive regulation of cell differentiation, growth hormone receptor signaling pathway, positive regulation of inflammatory response, induction of apoptosis by oxidative stress, regulation of inflammatory response, response to interleukin-12, positive regulation of interleukin-1 beta production, positive regulation of cell activation, peptide hormone receptor binding, enzyme linked receptor protein signaling pathway, activation of JAK2 kinase activity, JAK-STAT cascade involved in growth hormone signaling pathway, tyrosine phosphorylation of Stat3 protein, positive regulation of tyrosine phosphorylation of Stat3 protein, protein autophosphorylation, protein phosphorylation, interferon-gamma-mediated signaling pathway, interleukin-12-mediated signaling pathway, STAT protein import into nucleus, phosphatidylinositol 3-kinase binding, positive regulation of phosphatidylinositol 3-kinase cascade, positive regulation of sequence-specific DNA binding transcription factor activity
InterPro Term SH2, Se/Thr_prot_kinase-like_dom, Kinase-like_dom, Ser/Thr_prot_kinase_dom, Tyr_prot_kinase_AS, Prot_kinase_cat_dom, Band_41_domain, Tyr_Pkinase_cat_dom, Protein_kinase_ATP_BS, FERM_domain, Ser-Thr/Tyr-Pkinase, Tyr_kinase_non-rcpt_Jak/Tyk2, Tyr_kinase_non-rcpt_Jak2
UniProt Accession Q62689, F1M9X6
Search EB-eye ENSRNOG00000015547
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-19830, E-GEOD-20388, E-AFMX-7, E-GEOD-471, E-GEOD-464, ... (15 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-MEXP-31, E-TABM-130, E-GEOD-2032

Factor Value U/D Experiments
fibroblast
1
1
E-GEOD-2032
1
E-TABM-130
total testis
1
E-MEXP-31
spermatogonia
1
E-MEXP-31
Sertoli cell
1
1
1
E-MEXP-31, E-TABM-130
spermatocyte
1
1
E-MEXP-31, E-TABM-130
4 more value(s).


Disease state

studied in E-GEOD-594, E-GEOD-464, E-MTAB-104, E-MEXP-2583

Factor Value U/D Experiments
bone fracture
1
1
E-GEOD-594
Sham
1
E-MEXP-2583
BDL 7 days
1
E-MEXP-2583
bladder carcinoma
1
E-MTAB-104
normal
27
3
E-MTAB-104, E-GEOD-464, E-GEOD-594


Compound treatment

studied in E-GEOD-4236, E-MEXP-2098, E-MEXP-1169, E-GEOD-2331, E-GEOD-2303, ... (7 experiments)

Factor Value U/D Experiments
none
3
E-GEOD-2331, E-GEOD-4236, E-MEXP-2098
sulphated cholecystokinin-8
1
E-MEXP-1169
valproic acid
1
E-GEOD-2303
AICAR
1
E-GEOD-22647
interleukin 1 beta
1
1
E-GEOD-6119
LG100268
1
E-GEOD-2331
4 more value(s).


Clinical treatment

studied in E-MEXP-976, E-GEOD-7002, E-GEOD-738, E-GEOD-1685, E-MTAB-104 ... (5 experiments)

Factor Value U/D Experiments
spinal nerve transection
1
E-MEXP-976
internal plate
1
1
E-GEOD-1685
no implantation
1
E-MTAB-104
aortic banding - sham
1
1
E-GEOD-738
implanted tumor
1
E-MTAB-104
instillation
1
E-GEOD-7002
5 more value(s).


compound_treatment_design

studied in E-TABM-12

Factor Value U/D Experiments
17a-ethynylestradiol
1
E-TABM-12
bisphenol A
1
1
E-TABM-12
genestein
1
1
E-TABM-12


Day
studied in E-GEOD-20659

Developmental stage
studied in E-GEOD-4236, E-GEOD-903

Growth condition
studied in E-GEOD-1567, E-GEOD-20659, E-GEOD-491, E-MEXP-532, E-GEOD-19653 ... (5 experiments)

Individual
studied in E-TABM-536

Infection
studied in E-MEXP-1656

Injury
studied in E-GEOD-1371, E-GEOD-1685

Material type
studied in E-GEOD-4192, E-GEOD-467

protocol
studied in E-GEOD-20895

Protocol type
studied in E-GEOD-691, E-GEOD-1616, E-MEXP-1565

Replicate
studied in E-GEOD-4192

Sampling time point
studied in E-MEXP-1565

Scanner
studied in E-TABM-536

Strain or line
studied in E-GEOD-2116, E-MTAB-323

Treatment
studied in E-GEOD-16981, E-GEOD-19909

Processing time: 0.477 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM